LongBio Pharma (Suzhou) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	95.05	66.62	117.23
Trading Asset Securities	95.21	40.1	-
Cash & Short-Term Investments	190.26	106.72	117.23
Cash Growth	78.28%	-8.96%	-
Other Receivables	1.1	0.06	3.65
Receivables	1.1	0.06	3.65
Restricted Cash	0.88	-	-
Other Current Assets	9.83	16.62	4.45
Total Current Assets	202.07	123.4	125.32
Property, Plant & Equipment	13.04	18.14	19.13
Other Long-Term Assets	12.44	7.37	1.02
Total Assets	227.56	148.91	145.48
Accounts Payable	5.72	12.76	5.33
Accrued Expenses	32.27	12.06	13.21
Short-Term Debt	35	37.88	13
Current Portion of Long-Term Debt	-	23.64	22.43
Current Portion of Leases	2.13	4.11	3.62
Current Income Taxes Payable	-	-	0.04
Current Unearned Revenue	0.56	2.04	-
Other Current Liabilities	7.78	2.25	3.52
Total Current Liabilities	83.45	94.73	61.15
Long-Term Debt	-	379.13	270.47
Long-Term Leases	0.79	2.92	5.51
Long-Term Unearned Revenue	2.8	2.41	2.04
Total Liabilities	87.04	479.19	339.16
Common Stock	60	7.99	7.66
Additional Paid-In Capital	181.08	294.71	-
Retained Earnings	-110.89	-336.77	-199.45
Comprehensive Income & Other	10.32	-296.22	-1.9
Shareholders' Equity	140.52	-330.28	-193.69
Total Liabilities & Equity	227.56	148.91	145.48
Total Debt	37.92	447.68	315.03
Net Cash (Debt)	152.34	-340.96	-197.81
Net Cash Per Share	2.69	-7.18	-4.62
Filing Date Shares Outstanding	74.19	48.48	42.8
Total Common Shares Outstanding	60	48.48	42.8
Working Capital	118.62	28.67	64.18
Book Value Per Share	2.34	-6.81	-4.53
Tangible Book Value	140.52	-330.28	-193.69
Tangible Book Value Per Share	2.34	-6.81	-4.53
Machinery	20.14	18.46	17.89
Construction In Progress	-	-	5.01
Leasehold Improvements	9.64	8.81	-